Metastatic Cancer Clinical Trials

A listing of Metastatic Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Scottsdale Arizona 85258

A clinical research study of VS-4718 for the treatment of Non Hematologic Cancers or Metastatic Cancer

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Non Hematologic Cancers, Metastatic Cancer or Lymphoma

California

Stanford University Medical Center
Palo Alto California 94304

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Sarcoma Oncology Research Center
Santa Monica California 90403

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

NEW

Incyte Corporation
Whittier California

An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

View More ▼

Los Angeles California 90048

A clinical research study of VS-4718 for the treatment of Non Hematologic Cancers or Metastatic Cancer

Los Angeles California

A clinical trial to evaluate treatments using INCAGN01876 for patients with Advanced Cancer or Metastatic Cancer

Los Angeles California 90048

A Phase 1 clinical study for patients with Non Hematologic Cancers, Metastatic Cancer or Lymphoma

San Francisco California 94143

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

Sunnyvale California 94086

A clinical research study of BP31510 monotherapy and BP31510 in combination with chemotherapy for the treatment of Metastatic Cancer, Cancer or Refractory Solid Tumor

Colorado

University of Colorado Cancer Center
Aurora Colorado 80045

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

District of Columbia

MedStar Washington Hospital Center
Washington District of Columbia 20010

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Florida

Mayo Clinic of Jacksonville
Jacksonville Florida 32224

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

UPDATED

Fort Myers Florida 33916

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Sarasota Florida 34232

A clinical research study of VS-4718 for the treatment of Non Hematologic Cancers or Metastatic Cancer

UPDATED

St. Petersburg Florida 33705

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

UPDATED

Tampa Florida 33612

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Georgia

Georgia Cancer Specialists
Sandy Springs Georgia 30342

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Memorial University Medical Center
Savannah Georgia 31404

SWOG S1201: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer

View More ▼

Atlanta Georgia 30322

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

Illinois

AMITA Health
Arlington Heights Illinois 60005

Evaluation of Targeted Radiofrequency Ablation and Vetebral Augmentation prior to or following Radiation Therapy to Treat Painful Metastatic Vetebral Body Tumor(s) [The STARRT Study]

Northwestern University Feinburg School of Medicine
Chicago Illinois 60611

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Chicago Illinois 60611

Patients are needed to participate in a clinical research study of bevacizumab and quality-of-life assessment to evaluate Metastatic Cancer or Unspecified Adult Solid Tumor, Protocol Specific

Iowa

University of Iowa Hospital and Clinics
Iowa City Iowa 52242

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Kansas

UPDATED

Lenexa Kansas 66219

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Boston Massachusetts 02215

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

Michigan

UPDATED

Detroit Michigan 48201

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Minnesota

Mayo Clinic Rochester
Rochester Minnesota 10029

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Missouri

Washington University in St. Louis
St. Louis Missouri 63110

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

St. Louis Missouri 63110

A clinical research study of VS-4718 for the treatment of Non Hematologic Cancers or Metastatic Cancer

UPDATED

St. Louis Missouri 63110

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Nebraska

Research Center
Omaha Nebraska

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Nevada

Research Center
Las Vegas Nevada

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

New Jersey

Mirati Research Site
Hackensack New Jersey

A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

View More ▼

UPDATED

Marlton New Jersey 08053

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

New York

Mirati Research Site
Bronx New York 10461

A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

Tisch Cancer Institute
New York New York 10029

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

New York New York 10021

A clinical research study of BP31510 monotherapy and BP31510 in combination with chemotherapy for the treatment of Metastatic Cancer, Cancer or Refractory Solid Tumor

New York New York 10065

A clinical trial to evaluate treatments using LY3023414, Midazolam and Letrozole for patients

New York New York 10065

A Phase 1 clinical study for patients with Non Hematologic Cancers, Metastatic Cancer or Lymphoma

New York New York 10032

Patients are needed to participate in a clinical research study of bevacizumab and quality-of-life assessment to evaluate Metastatic Cancer or Unspecified Adult Solid Tumor, Protocol Specific

North Carolina

Levine Cancer Institute
Charlotte North Carolina 28204

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Duke Cancer Institute
Durham North Carolina 27710

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

View More ▼

Huntersville North Carolina 28078

Patients are needed to participate in a clinical research study for the treatment of Metastatic Cancer

Oklahoma

Oklahoma City Oklahoma 73104

A clinical trial to evaluate treatments using LY3023414, Midazolam and Letrozole for patients

Oregon

NEW

Incyte Corporation
Portland Oregon

An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Pennsylvania

NEW

Incyte Corporation
Bethlehem Pennsylvania

An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Fox Chase Cancer Center
Philadelphia Pennsylvania 19111

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)